CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 111 filers reported holding CLOVIS ONCOLOGY INC in Q4 2013. The put-call ratio across all filers is 0.91 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $58,368,000 | +100.7% | 634,718 | +91.8% | 0.03% | +8.3% |
| Q2 2015 | $29,082,000 | +19.4% | 330,929 | +0.8% | 0.02% | +20.0% |
| Q1 2015 | $24,366,000 | -13.7% | 328,253 | -34.9% | 0.02% | -16.7% |
| Q4 2014 | $28,231,000 | +153.5% | 504,123 | +87.4% | 0.02% | +140.0% |
| Q2 2014 | $11,138,000 | -36.1% | 268,977 | +6.8% | 0.01% | -37.5% |
| Q1 2014 | $17,441,000 | +60.3% | 251,789 | +39.5% | 0.02% | +60.0% |
| Q4 2013 | $10,880,000 | +13.3% | 180,529 | +14.2% | 0.01% | 0.0% |
| Q3 2013 | $9,607,000 | +23.5% | 158,065 | +36.0% | 0.01% | +25.0% |
| Q2 2013 | $7,782,000 | – | 116,185 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,402,781 | $231,389,000 | 9.96% |
| Versant Venture Management, LLC | 101,855 | $6,926,140,000 | 7.29% |
| Avoro Capital Advisors LLC | 1,102,884 | $74,996,000 | 4.86% |
| Redmile Group, LLC | 1,320,027 | $89,762,000 | 3.90% |
| NEXTHERA CAPITAL LP | 233,200 | $15,858,000 | 2.92% |
| Iguana Healthcare Management, LLC | 60,000 | $4,080,000 | 2.66% |
| HealthCor Management, L.P. | 973,840 | $66,221,000 | 2.16% |
| Casdin Capital, LLC | 127,500 | $8,670,000 | 2.11% |
| Prosight Management, LP | 40,000 | $2,720,000 | 2.00% |
| Camber Capital Management LP | 600,000 | $40,800,000 | 2.00% |